ENTITY
Yunnan Baiyao Group Co.,

Yunnan Baiyao Group Co., (000538 CH)

56
Analysis
Health CareChina
Yunnan Baiyao Group Co., Ltd. manufactures and markets traditional Chinese medicines. The Company also operates in pharmaceutical wholesale and retail trading, empty capsules manufacturing, and hotel operation.
more
30 Mar 2023 08:55

China Traditional Chinese Medicine (TCM) Industry - TCM Is Becoming Indispensable in the Portfolio

The current policy environment in China indicates that TCM is core asset of pharmaceuticals, not innovative drug R&D. It''s time to take TCM...

Logo
332 Views
Share
10 Nov 2022 09:24

Shanghai Pharmaceuticals (2607.HK)- Low Profitability Is Big Problem; Share Price Would Underperform

Due to VBP, Shanghai Pharmaceuticals will face low margin. Weak COVID vaccine demand/uncertain synergistic effect of cooperation with Yunnan Baiyao...

Logo
265 Views
Share
05 Sep 2022 08:47

Beijing Tongrentang (600085.CH)- Neither Brand Nor Angong Niuhuang Pills Can Secure Future Prospects

Angong Niuhuang Pill is the major performance driver. Due to economic downturn, its price hike will lead to inventory overstocking. Without high...

Logo
279 Views
Share
18 Aug 2022 08:55

Pre-IPO Weimeizi (Guangdong) - The Market Position Is Not Solid

WEIMEIZI develops oral care market via large promotion, but its market position is not solid due to fierce competition, unless it could create...

Logo
319 Views
Share
02 May 2022 09:55

Northbound Flows: Shenzhen Inovance, Nari Technology

We highlight weekly Hong Kong Connect northbound inflows into Moutai, Yunnan Baiyao, Media Group, Shenzhen Inovance and Nari Technology.

Logo
283 Views
Share
x